Asset Manager

Updated:

Jiangsu Xintiandi Investment Group

Jiangsu Xintiandi Investment Group is a group company focused on venture capital, industrial development, and professional consulting. It has made three...

Jiangsu Xintiandi Investment Group

Jiangsu Xintiandi Investment Group is a group company focused on venture capital, industrial development, and professional consulting. It has made three investments. The group invested in Kebiao Medical through Seed VC - II on December 08, 2022.

General information

Firm type

Generalist

Location

Region

Asia

Country

China

City

Changzhou

Corporate office

51 Xiheyan, Zhonglou District, Changzhou, Jiangsu, China

Additional offices

Wujin Economic Development Zone, Changzhou, Jiangsu, China

Principals

Zhu Weizhong

Chairman and General Manager

Tang Qianmei

Shareholder, 40%

Lin Xiaohong

Board Member and General Manager Assistant

Sector focus

Medical DevicesReal EstateHealthcare Services

Frequently asked questions

Who controls Jiangsu Xintiandi Investment Group?

Zhu Weizhong holds a 60% majority stake as Chairman and General Manager. Tang Qianmei owns the remaining 40%. Lin Xiaohong serves as Board Member and General Manager Assistant. No external institutional investors or minority partners have been identified.

What is the firm's relationship with Changzhou University?

The two co-founded the Changzhou Medical Device Industry Research Institute, a joint venture that combines university research capabilities with commercial incubation. The institute operates from No. 9 Changyang Road, E4 Building in the Wujin Economic Development Zone of Changzhou, per public record.

What does Jiangsu Xintiandi invest in?

The group targets growth-stage medical-device and healthcare companies, with a portfolio concentrated in Jiangsu province. It also holds commercial and mixed-use real estate assets, including its headquarters building and the institute property.

Does the firm raise external capital or operate as a family office?

Based on public record, the shareholding structure — with Zhu Weizhong at 60% and Tang Qianmei at 40% — suggests a closely held vehicle, likely family-controlled, rather than a third-party fund manager. No evidence of external LP commitments has been identified.

Does Jiangsu Xintiandi maintain any philanthropic structures?

The Changzhou Medical Device Entrepreneurship Service Center functions as an incubation and support entity for startups affiliated with the institute. Whether it is formally registered as a charitable foundation is not publicly disclosed; the structure is described as a service center.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Changzhou Generalist profiles